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Abstract
Pathologies caused by mutations in extracellular matrix proteins are generally considered to result from the synthesis of
extracellular matrices that are defective. Mutations in type X collagen cause metaphyseal chondrodysplasia type Schmid
(MCDS), a disorder characterised by dwarfism and an expanded growth plate hypertrophic zone. We generated a knock-in
mouse model of an MCDS–causing mutation (COL10A1 p.Asn617Lys) to investigate pathogenic mechanisms linking
genotype and phenotype. Mice expressing the collagen X mutation had shortened limbs and an expanded hypertrophic
zone. Chondrocytes in the hypertrophic zone exhibited endoplasmic reticulum (ER) stress and a robust unfolded protein
response (UPR) due to intracellular retention of mutant protein. Hypertrophic chondrocyte differentiation and osteoclast
recruitment were significantly reduced indicating that the hypertrophic zone was expanded due to a decreased rate of
VEGF–mediated vascular invasion of the growth plate. To test directly the role of ER stress and UPR in generating the MCDS
phenotype, we produced transgenic mouse lines that used the collagen X promoter to drive expression of an ER stress–
inducing protein (the cog mutant of thyroglobulin) in hypertrophic chondrocytes. The hypertrophic chondrocytes in this
mouse exhibited ER stress with a characteristic UPR response. In addition, the hypertrophic zone was expanded, gene
expression patterns were disrupted, osteoclast recruitment to the vascular invasion front was reduced, and long bone
growth decreased. Our data demonstrate that triggering ER stress per se in hypertrophic chondrocytes is sufficient to induce
the essential features of the cartilage pathology associated with MCDS and confirm that ER stress is a central pathogenic
factor in the disease mechanism. These findings support the contention that ER stress may play a direct role in the
pathogenesis of many connective tissue disorders associated with the expression of mutant extracellular matrix proteins.
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Introduction
Most bones in the body grow by a process of endochondral
ossification in which a cartilage template is laid down and subsequently
converted to bone. The process takes place in well-defined growth
plates at the ends of long bones. Longitudinal bone growth is achieved
in a tightly controlled process in which chondrocytes first proliferate
forming columns, then exit the cell cycle, hypertrophy and mineralise
[1,2]. Collagen X is expressed solely and specifically by hypertrophic
chondrocytes although the precise function of this protein in bone
growth remains controversial. Roles for collagen X as an extracellular
scaffold or in the mineralisation of hypertrophic growth plate have
been proposed and yet most studies have shown that gene ablation
does not produce an overt phenotype in mice [3,4]. Terminally
differentiated hypertrophic chondrocytes die by programmed cell
death as blood vessels invade the calcified region of the growth plate.
The vasculature introduces osteoclasts which erode the mineralised
cartilage matrix and osteoblasts which replace the cartilage matrix with
bone. The differentiation process is controlled by a cascade of growth
factors including PTHrP, Indian Hedgehog and VEGF [2,5,6].
Mutations in cartilage extracellular matrix (ECM) proteins such as
collagens II, IX, X and XI, aggrecan, COMP and matrilin 3 disrupt
growth plate differentiation and cause chondrodysplasia [7–9]. In
these types of dysplasia, it is generally thought that the pathology
arises as a result of an ECM that is either defective due to the
incorporation of the mutant protein or alternatively, deficient in the
protein due to intracellular degradation of the mutated protein prior
to secretion. However, it is becoming increasingly clear that the
synthesis of mutant proteins destined for the ECM can trigger ER
stress in affected cells eliciting an UPR [10–18]. The UPR is
orchestrated through the interaction of the molecular chaperone BiP
(Grp78) with a set of transmembrane ER stress sensors (IRE1, ATF6,
PERK). BiP normally binds to these membrane bound sensors but as
ER stress increases, BiP is sequestered into the ER lumen by
interaction with accumulating unfolded proteins. Loss of BiP binding
causes the stress sensors to activate resulting in downstream events
PLoS Genetics | www.plosgenetics.org 1 October 2009 | Volume 5 | Issue 10 | e1000691such as Xbp-1 splicing, ATF6 cleavage, eIF2a phosphorylation and
ATF4 translation (extensively reviewed in [19–22]). As a result, the
s y n t h e s i so fs t r e s sr e l a t e dp r o t e i n ss u c ha sc h a p e r o n e sl i k eB i Pa r e
increased to enhance the protein folding capacity of the ER. General
protein synthesis is decreased through phospho eIF2a-dependant
translational suppression of 59 cap containing mRNAs to slow down
the entry of unfolded protein into the ER. In addition, relevant
pathways for disposing of misfolded proteins such as ER associated
degradation or autophagy are up-regulated.
Mutations in type X collagen, predominantly clustered in the C-
terminal non collagenous (NC1) domain that is required for collagen
trimer assembly, cause MCDS, a relatively mild form of dwarfism
[4,23,24]. Two recent studies of transgenic mouse lines expressing
MCDS-associated mutations, a 13 bp deletion in the NC1 coding
region of the gene [11] and the mouse equivalent of the COL10A1
p.Pro620fsX621 mutation [13], have reported a UPR in the collagen
X-expressing hypertrophic zone of the growth plate and provided
strong evidence for ER stress playing an important role in the
pathogenesisof this disease. Wegenerated a knock-in mousemodel of
the COL10A1 p.Asn617Lys MCDS-causing mutation and demon-
strate that the MCDS-associated expanded hypertrophic zone
[11,13] occurred because of disrupted VEGF-mediated osteoclast
erosion of the mineralised cartilage at the vascular invasion front. ER
stress and a strong UPR provoked by misfolding mutant collagen X
were key features of the hypertrophic chondrocytes in the MCDS
mouse. Furthermore the targeted stimulation of ER stress in
hypertrophic chondrocytes in vivo was sufficient to replicate the
MCDS growth plate phenotype functionally demonstrating the
c e n t r a lr o l ep l a y e db yE Rs t r e s si nt h ed i s e a s em e c h a n i s m .
Results
Generation of a collagen X (p.Asn617Lys) knock-in mouse
model of MCDS
Mice harbouring the p.Asn617Lys mutation in the NC1 domain
of collagen X that causes MCDS in humans were generated
following homologous recombination in R1 ES cells. The
AACRAAA codon change was introduced into exon 3 of the
Col10a1 gene by site directed mutagenesis. Of the 360 G418
resistant ES cell clones selected and analysed, 7 were shown to be
homologously recombined by Southern blotting (Figure 1B) and 5
of these were found to contain the mutation by direct sequencing
(data not shown). Three correctly targeted clones were transiently
transfected with an expression vector containing cre recombinase
to delete the floxed selection cassette. Germline chimeras were
generated from one of these clones. The mutant allele was
detected by a PCR assay (Figure 1C) and the presence of the
mutated base causing the p.Asn617Lys substitution confirmed by
direct sequencing of the genomic DNA of mutant offspring
(Figure 1D).
Mice heterozygous and homozygous for the substitution will
now be referred to as wt/m and m/m respectively, with wildtype
littermates being denoted as wt/wt.
Knock-in mice develop a short-limbed dwarfism
Neither wt/m or m/m mice had any overt skeletal phenotype at
birth (Figure 2A). The growth rates of wt/m and wt/wt mice were
indistinguishable whereas the m/m mice were growth retarded
(Figure 2B; Table 1).
Skeletal analyses at 11 week of age revealed that m/m mice had
shorter endochondral bones than their wt/wt littermates
(Figure 2C and 2D). The femurs of m/m animals were between
14 and 21% shorter than wt/wt controls over the time course of
the experiment (Table 1). The lengths of femurs in the wt/m mice
were intermediate between the wt/wt and m/m values from 2
weeks of age onwards and the reduction in bone lengths in wt/m
animals reached statistical significance at 2 and 3 weeks of age
when compared to control wt/wt mice (p,0.05; Table 1). The
differences between wt/wt and m/m femur length were
maintained at 1 year of age (mean6SEM (n): wt/wt
16.360.3 mm (5); wt/m 15.660.7 mm (6); m/m 13.661.3 mm
(7); wt/wt or wt/m versus m/m p,0.01). Pelvis shape was
distorted (Figure 2C and 2D) and pelvis length significantly shorter
in m/m compared to wt/wt mice from 1 week of age. The pelvic
distortion was not apparent in wt/m mice but there was a
detectable, albeit not significant, decrease in pelvis length
compared to wt/wt mice at most ages examined (Figure 2C;
Table 1). The skull, which is formed largely by intramembranous-
rather than endochondral- ossification was unaffected by genotype
(Figure 2C) with inner canthal distances at 10 weeks of age being
wt/wt 0.7760.01 mm, wt/m 0.8160.01 mm and m/m
0.8160.03 mm (no significant differences).
Growth plate hypertrophic zone expansion in mice
expressing mutant collagen X
The hypertrophic zones of tibial growth plates were markedly
expanded in m/m animals (Figure 3A). Such expansions were also
apparent in growth plates from other bones such as the femur and
ribs (data not shown). The expansion of the hypertrophic zone was
apparent at birth in m/m compared to wt/wt animals and was still
apparent at 7 weeks of age even though the overall width of the
growth plate in all genotypes decreased by approximately 70%
over this period (Figure 3A and 3B). In wt/m mice, a significant
(approx. 35%) expansion of the hypertrophic zone was apparent at
3 weeks of age but had resolved by 7 weeks of age (Figure 3A and
3B). There was no overt effect upon the pattern of trabecular bone
deposition beneath the expanded growth plates in mutant mice
(Figure 3A; 7 week samples).
No significant differences in the chondrocyte proliferation rates
were detected between genotypes (Figure 3C and 3D) ruling out
the possibility that increased proliferation of chondrocytes
Author Summary
Mutations in genes for extracellular matrix proteins are
generally thought to exert their pathogenic effects
because of resulting defects in extracellular matrix.
However, it is becoming increasingly clear that such
mutations can also have significant effects inside the cell
due to the induction of ER stress. Mutations in type X
collagen cause a dwarfism called metaphyseal chondro-
dysplasia type Schmid. A gene targeted mouse model
expressing mutant type X collagen exhibited an expanded
hypertrophic zone of the growth plate and significant
increases in cellular ER stress, as noted previously. VEGF
expression was disrupted leading to decreases in the rate
of vascular invasion. To directly assess the role of elevated
ER stress in disease pathogenesis, transgenic mouse lines
expressing an exogenous, ER stress–inducing protein (cog
mutant of thyroglobulin—Tg
cog) targeted to hypertrophic
chondrocytes were generated. Mice expressing Tg
cog
protein showed elevated ER stress, an expanded hyper-
trophic zone, and reduced bone growth demonstrating
that elevated ER stress and the resultant UPR is the
principal pathogenic mechanism causing this cartilage
pathology. It is possible that therapeutic strategies aimed
at alleviating ER stress may be beneficial in this and other
connective tissue diseases caused by mutant extracellular
matrix genes.
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mutant collagen X.
Collagen X secretion is delayed and hypertrophic
chondrocyte differentiation disrupted in mutant mice
Immunolocalisation of collagen X revealed the expected
extracellular staining in the hypertrophic zones of control growth
plates with no obvious intracellular staining (Figure 4A; wt/wt).
However, the secretion of mutant collagen X was reduced and
significantly delayed in m/m mice with marked intracellular
retention of the mutant protein apparent in the upper hypertro-
phic zone (Figure 4A). Immunolocalisation of collagen X in wt/m
animals appeared unaffected compared to wt/wt apart from an
occasional hypertrophic cell showing some intracellular immuno-
reactivity (data not shown).
In situ analysis revealed that collagen X mRNA expression was
increased in hypertrophic chondrocytes of wt/wt mice (Figure 4B).
Wt/m mice exhibited an expression pattern similar to that of the
wt/wt controls. m/m mice also showed collagen X induction in
the upper hypertrophic zone but this was followed by down-
regulation and then re-expression producing a ‘speckled’ appear-
ance in the lower hypertrophic zone (Figure 4B). The expression of
BiP mRNA was below the level of detection in wt/wt controls
whereas it is clearly up-regulated in the hypertrophic zone of wt/m
Figure 1. Generation of the Col10a1 p.Asn617Lys MCDS mouse model. (A) Targeting strategy: (i) Wildtype collagen X allele indicating
location of probes used for Southern blotting and relevant restriction enzyme sites; exons are numbered boxes and the region of exon 3 encoding
the collagenous domain is indicated by dappling; (ii) Targeting construct with p.Asn617Lys (N617K) mutation (*) and floxed Neo TK selection cassette;
(iii) Recombinant allele identified using the external probe; (iv) Mutant knock-in allele containing the p.Asn617Lys mutation and residual LoxP site
following deletion of the Neo TK cassette by transient Cre transfection and FIAU selection. (B) Positive clones were selected by screening EcoRV
digested DNA with the external probe. Southern blot analysis was used to identify homologously recombined clones (Q) containing both the
wildtype allele (19 kb) and the recombinant allele (9 kb). (C) Genotyping was performed by PCR amplification across the residual LoxP site using F and
R primers shown in (A). (D) Chromatograph of the sequence flanking the mutation site from F2 mice, showing the C.A single base pair substitution
in the heterozygote (wt/m), represented by a double peak, and the single A peak in the mouse homozygous for the mutation (m/m).
doi:10.1371/journal.pgen.1000691.g001
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PLoS Genetics | www.plosgenetics.org 3 October 2009 | Volume 5 | Issue 10 | e1000691Figure 2. Macroscopic analyses of the MCDS mouse phenotype. (A) Skeletal preps of new born mice stained with alizarin red (bone) and
alcian blue (cartilage). (B) Growth curves of mice (females) heterozygous (wt/m) and homozygous (m/m) for collagen X p.Asn617Lys mutation,
compared to wild-type (wt/wt) litter mates. (C) X-ray images of male mice at 11 weeks of age, scale bar=1 cm. (D) Comparison of bone lengths
between wt/wt and m/m mice: (i) pelvis; (ii) femur, vertical white scale bar=1 cm.
doi:10.1371/journal.pgen.1000691.g002
Table 1. Body measurements of Col10a1 p.Asn617Lys mutant mice.
Measurement Genotype New born 1 week 2 week 3 week 10 week
Body weights (g) wt/wt - 5.260.3 (4) 6.960.7 (4) 10.860.4 (4) 25.561.6 (7)
wt/m - 5.160.3 (6) 7.960.5 (6) 10.860.8 (6) 25.361.7 (14)
m/m - 3.760.5 (7) ** 4.860.7 (7) * 8.860.8 (7) ** 22.861.5 (8) **
Femur Length (mm) wt/wt 2.160.1 (4) 5.060.1 (7) 7.760.1 (4) 8.261.5 (7) 13.760.4 (4)
wt/m 2.160.1 (5) 4.960.1 (11) 7.160.1 (6)
{ 7.561.4 (7)
{ 12.760.5 (6)
m/m 2.060.1 (6) 4.360.1 (7)
{{ # 6.160.1 (4) ** 6.961.2 (7)
{{ # 11.060.3 (4) *
Pelvis Length (mm) wt/wt 3.260.1 (4) 8.360.2 (7) 10.660.5 (4) 10.660.2 (7) 17.960.4 (4)
wt/m 3.360.1 (5) 7.860.1 (11) 10.260.1 (6) 9.860.2 (7) 17.760.2 (6)
m/m 2.960.1 (6) 6.660.2 (7) * 8.260.1 (4) ** 8.860.2 (7)
{{ # 15.560.1 (4) **
Mean6SEM (n): *p,0.05 when compared to wt and wt/m; **p,0.001 when compared to wt/wt and wt/m;
{p,0.05 when compared to wt/wt;
{{p,0.001 when
compared to wt/wt;
#p,0.05 when compared to wt/m.
doi:10.1371/journal.pgen.1000691.t001
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the upper hypertrophic zone and expression became sporadic in
the lower hypertrophic zone similar to that seen for collagen X
expression in the mutant mice. In wt/wt and wt/m mice, collagen
II expression was down-regulated in the hypertrophic compared to
proliferative zone. In m/m mice, collagen II mRNA was down-
regulated in the upper hypertrophic zone but became strongly up-
regulated in scattered cells in the lower portion of elongated
hypertrophic zone (Figure 4B). Expression of osteopontin, a
marker of terminal hypertrophic chondrocyte differentiation, was
restricted to a narrow region of hypertrophic chondrocytes at the
base of the growth plate in wt/wt and wt/m mice but was
expressed by individual cells scattered throughout the lower half of
the elongated hypertrophic zone in m/m mice (Figure 4B).
Chondrocytes expressing the mutant collagen X exhibit
increased ER stress and the UPR
The intracellular retention of mutant collagen X (Figure 4A) and
the up-regulation of BiP mRNA (Figure 4B) are signs that the
hypertrophic chondrocytes are experiencing increased levels of ER
stress. We therefore conducted western blotting analyses of rib
growth plate extracts to biochemically characterize this cellular
response. The levels of BiP protein were higher in both wt/m and
m/m extracts than those from wt/wt growth plate (Figure 5). Full
length ATF6 (,90 kDa) was not detectable in control extracts
(Figure 5; wt/wt). However, the cleaved ,50 kDa active form of
ATF6 was readily detected in both wt/m and m/m growth plate
extracts inferring that ATF6 was significantly induced and activated
in hypertrophic chondrocytes expressing the mutant collagen X.
Figure 3. Analysis of hypertrophic zone width. (A) H & E staining of tibial growth plates from new born, 3 week and 7 week old MCDS and
control mice. The hypertrophic zone is indicated by the vertical red brackets; horizontal white scale bar=100 mm. (B) Hypertrophic zone widths at
specified time points. *p,0.05, **p,0.01 versus control (wt/wt). (C) 5-bromo-29-deoxyuridine (BrdU) labelling of proliferative cells in the growth plate
of 3 week old mice. Positive cells stained black. (D) Graph showing the percentage of BrdU positive cells within the proliferative zone. The number of
labelled cells in 4 different sections from 5 wt/wt, 5 wt/m and 4 m/m animals were counted.
doi:10.1371/journal.pgen.1000691.g003
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disrupted VEGF expression and a resulting decreased
recruitment of osteoclasts to the vascular invasion front
VEGF expression by hypertrophic chondrocytes has previously
been shown to play an important role in mediating the width of
the hypertrophic zone through modulating the rate of vascular
invasion [6,25]. VEGF expression was readily detected in wildtype
growth plate where expression was localised to the lower half of
the hypertrophic zone. No such synchronised expression was
detected in the expanded hypertrophic zone of the m/m mice
(Figure 6A). It therefore appears that VEGF can be added to the
list of genes described above (Figure 4) and previously [11,13]
whose expression by hypertrophic chondrocytes is disrupted as a
result of mutant collagen X expression. Vascular invasion of the
base of the growth plate introduces osteoclasts to the vicinity and it
is these cells that are responsible for eroding the cartilage matrix
allowing its replacement by bone. Tartrate-resistant acid phos-
phatase (TRAP) staining for osteoclasts revealed significantly fewer
osteoclasts localised to the vascular invasion front in m/m
compared to wt/wt growth plates (p,0.01; Figure 6B).
Targeted expression of the Tg
cog protein in hypertrophic
chondrocytes induces increased ER stress and the UPR
The expression of MCDS-causing collagen X mutations in vivo
results in an expanded hypertrophic zone with cells exhibiting a
robust UPR which has been proposed to play a key role in disease
pathogenesis ([11,13] and data presented above). In order to directly
test the roleof UPRinthe disease mechanism,we generated a mouse
in which ER stress would be targeted to hypertrophic chondrocytes
independently from the expression of a mutant collagen X protein.
Figure 4. Histological characterisation of 3-week-old tibial growth plates. (A) Collagen X immunohistochemistry for MCDS and control
mice. Purple staining indicates collagen X localisation; The black boxed photomicrographs represent an expanded view of the indicated areas in the
sections from 3 week old mice. The intracellular accumulation of collagen X in the m/m growth plates is apparent in the upper hypertrophic zone.
The transition region in which intracellular accumulation of collagen X resolves accompanied by a limited secretion of mutant collagen X is indicated
by the white horizontal arrows in the expanded view of the 3 week m/m sample. (B) In situ hybridisation for Col10a1, BiP, Col2a1 (collagen II) and Opn
(osteopontin) in tibial growth plate sections from 3 week old animals. The presence of the transcript is indicated by blue staining. The hypertrophic
zone is indicated by the vertical red brackets.
doi:10.1371/journal.pgen.1000691.g004
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thyroid hormones and its expression is restricted to thyroid cells.
The cog mutant of thyroglobulin (Tg
cog) provokes a strong UPR
due to its inability to dimerise in the ER, an obligate step for
thyroglobulin secretion. As a result, Tg
cog is efficiently retained
intracellularly [26,27]. The expression of Tg
cog was targeted to
hypertrophic chondrocytes through coupling to the collagen X
promoter (ColXTg
cog, Figure 7A). Transgenic mice were created by
pronuclear injection and 2 independent lines that expressed the
Tg
cog protein in hypertrophic chondrocytes (Figure 7B) were
investigated further and gave similar results. One mouse line had
approximately 5 copies of the transgene at a single insertion site
and expressed 17% and 33% the level of endogenous collagen X
in the hemizygous and homozygous state, respectively (results of
collagen X and transgene qPCR not shown). This line was used to
generate the data presented herein. Hemizygous and homozygous
transgenic mice will be referred to as +/c and c/c respectively, and
wildtype littermate controls as +/+.
BiP protein was elevated in +/c or c/c rib growth plate extracts
when compared with +/+ controls (Figure 8). As noted previously
(Figure 5), full-length (,90 kDa) ATF6 was not detectable in
wildtype controls but the cleaved activated form of the protein
(,50 kDa) was markedly induced in both +/c and c/c mice
(Figure 8). The increased levels of BiP and cleaved ATF6 are clear
indications that the expression of Tg
cog in hypertrophic chondro-
cytes elevated ER stress and induced an UPR with similar
characteristics to that caused by the mutant collagen X (cf Figure 5
and Figure 8).
The expression of Tg
cog protein in hypertrophic
chondrocytes causes an expanded hypertrophic zone
and decreased bone growth
New born and 3 week old +/c and c/c mice exhibited an
expanded hypertrophic zone (Figure 9A). The hypertrophic zone
in new born c/c mice was 80% thicker than +/+ controls
Figure 5. Western blot analysis of MCDS mouse growth plate
extracts. The panels represent two independent analyses of growth plate
extracts from wildtype (wt/wt), heterozygote (wt/m) and mice homozygous
(m/m) for the Col10a1 p.Asn617Lys mutation. For each analysis, growth
plates from the ribs of two 21 day old mice were pooled and extracted in
sample buffer as described in the methods. Twenty micrograms of each
extract was resolved on SDS-PAGE gels under reducing conditions, and
western blotted for BiP and ATF6. Cooma s s i eb l u es t a i n e dg e l sa r ep r o t e i n
loading controls. For the ATF6 blot, the cleaved form (50 kDa indicated by
arrow) was readily detected in wt/m and m/m mouse extracts whereas the
full-length ATF6 (90 kDa) was not detected in any samples. A non-specific
band at about 70 kDa (arrow head) was apparent.
doi:10.1371/journal.pgen.1000691.g005
Figure 6. VEGF expression and osteoclast recruitment at the vascular invasion front. (A) VEGF in situ hybridisation by
35S-labelled
riboprobe and autoradiography: (i) light-field and (ii) dark field view of the same regions of the growth plate sections. (B) TRAP staining for osteoclasts
at the vascular invasion front (vif - arrow heads, hz=hypertrophic zone); (i) Vertical arrows indicate positively stained cells (red/brown colour); (ii)
Histogram depicting number of positive cells per 1 mm of vascular invasion front. *p,0.01 (n=3 for each genotype).
doi:10.1371/journal.pgen.1000691.g006
ER Stress and Growth Plate Pathology
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thicknesses. At 3 weeks of age, the hypertrophic zones of +/c and
c/c animals were increased 3- and nearly 4-fold respectively
compared to controls (Figure 9A; p,0.001 vs +/+ for each group).
However, at 6 weeks of age, the hypertrophic zone expansion
apparent at younger ages in the +/c and c/c mice had largely
resolved (Figure 9A).
Expression of Tg
cog protein in hypertrophic chondrocytes did not
affect the normal secretion of collagen X (Figure 9B). TRAP staining
revealed significant reductions in the numbers of osteoclasts localised to
the vascular invasion front in mice expressing the Tg
cog protein
(Figure 9C). X-ray analysis (Figure 9D) revealed that at 3 weeks, the
femurs of c/c mice were significantlyshorter than +/+controls and at 6
weeks of age, the femurs of +/c and c/c mice were approximately 6%
shorter than the +/+ controls (p,0.05; Figure 9E). However, by 10
weeks of age, long bone growth in ColXTg
cog mice was indistinguishable
from that of the age-matched controls (Figure 9E). A slight distortion of
the pelvis was apparent in +/c and c/c mice (Figure 9D).
The disruption of gene expression induced by Tg
cog is
similar to that caused by mutant collagen X
Direct comparison of the growth plates of 3 week old c/c or m/
m mice revealed that the expansion of the hypertrophic zone
appears greater in the m/m line (Figure 10). Thyroglobulin
expression was only apparent in the hypertrophic zone of the c/c
mouse and was not detectable in either +/+ or m/m mice
(Figure 10). Thyroglobulin expression (which is driven by the
Col10a1 promoter in the growth plate of the c/c mouse) was
induced at the boundary between the proliferative and hypertro-
phic zones. The expression of thyroglobulin was subsequently
down-regulated and then up-regulated in an uncoordinated
fashion further down the expanded hypertrophic zone in the c/c
mouse growth plate (Figure 10). Similarly, the wildtype collagen X
expressed by the c/c mouse was induced at the boundary of the
proliferative and hypertrophic zone but then down-regulated and
subsequently up-regulated in sporadic cells in the lower part of the
expanded hypertrophic zone. The disruption of collagen X
expression appeared greatest in the m/m mouse growth plate.
BiP expression, was markedly up-regulated in the upper
hypertrophic zone of the c/c mouse in a similar fashion to that
of the m/m mouse (Figure 10). In each line, BiP expression
appeared to mirror the expression of the mutant, ER-stress
inducing protein (Tg
cog and collagen X respectively). Collagen II
expression, which is normally down-regulated in the hypertrophic
zone was subsequently re-expressed by cells distributed sporadi-
cally in the lower hypertrophic zone of the c/c mouse in a similar
Figure 7. Generation of the ColXTg
cog mouse. (A) Schematic of the ColXTg
cog construct. The collagen X promoter as ligated upstream of the
cDNA sequence encoding the myc-tagged cog mutant form of thyroglobulin (Tg
cog). The cloning vector was removed and the construct injected into
mouse embryo pronuclei; (B) Immunohistochemical localisation of Tg
cog using a myc antibody on tibial growth plate section from a 3 week old
control (+/+) and a transgenic ColXTg
cog littermate (c/c). Expression of Tg
cog is limited to the hypertrophic zone of the transgenic (c/c) mouse.
doi:10.1371/journal.pgen.1000691.g007
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PLoS Genetics | www.plosgenetics.org 8 October 2009 | Volume 5 | Issue 10 | e1000691but less severe fashion to that seen in the m/m mouse (Figure 10).
The normal expression of osteopontin by only the most terminal of
the hypertrophic chondrocytes was disrupted in the c/c growth
plate in a similar fashion to the m/m mouse. Sporadic cells
scattered throughout the lower half of the expanded hypertrophic
zone turned on osteopontin expression in an uncoordinated
fashion (Figure 10).
Discussion
MCDS is a genetically dominant metaphyseal chondrodysplasia
thatresultsinarelativelymilddwarfism.Inspontaneouslyoccurring
forms of MCDS in man [13] and pig [28], an expansion of the
collagen X-expressing hypertrophic zone of the growth plate is
associated with the decreased rates of longitudinal bone growth. In
wt/m mice, a decrease in bone length accompanied by a growth
plate hypertrophic zone expansion was apparent at 3 weeks of age
comparedtocontrols(Table1;Figure3).Thisisclosetotheage that
peak growth rates are achieved in mice [29]. A more severe
pathologywasapparentinm/mmice(Table1;Figure2).Thepelvis
distortion apparent in m/m mice (Figure 2) was present at birth and
was not affected by increased rates of exercise stimulated by the
provision of wheel running facilities (data not shown). The pelvis
distortion appears to result from the decreased rates of growth from
the complex organisation of multiple growth plates that form this
bone and similar distortions are exhibited by mouse models of
diastrophic dysplasia and pseudoachondroplasia [14,30].
Immunohistochemical localisation of collagen X in the m/m
mice revealed intracellular retention of the mutant collagen X in
the upper hypertrophic zone followed by a delayed and limited
secretion in the lower part of the zone (Figure 4). These findings
are in agreement with cell culture analyses which demonstrated
that the collagen X with the p.Asn617Lys and other MCDS
missense mutations misfold in the ER, are poorly secreted and
induce increased levels of ER stress with a resulting UPR [10]. An
increased level of ER stress within the hypertrophic zone of mice
expressing the mutant collagen X was apparent from the up-
regulation of mRNA encoding BiP (Figure 4B), a key indicator of
the UPR [31,32]. Western blotting of mutant mouse growth plate
extracts revealed further evidence of an UPR including elevated
levels of BiP protein as well as induction and cleavage of ATF6.
Paradoxically, BiP protein levels appeared slightly more elevated
in the growth plate extracts from wt/m rather than m/m collagen
X mutant mice (Figure 5) as was also apparent in the equivalent
western blots from the ColXTg
cog mouse (Figure 8). In the wt/m
growth plate, most of the hypertrophic chondrocytes expressed
increased levels of BiP, based on in situ hybridisation, whereas in
the m/m animals, the majority of cells in the (lower) hypertrophic
zone did not express increased BiP (Figure 4). Whole growth plates
were used to prepare the protein extracts and a fixed quantity of
protein (20 mg) loaded per track. 4). Since a greater proportion of
the total cells in the wt/m compared to m/m growth plate were
expressing high levels of BiP, the levels of BiP protein in the wt/m
track (Figure 5) appear marginally higher. It is noteworthy that
recent studies of mouse lines expressing randomly integrated
MCDS-associated mutant collagen X transgenes (Col10a1.13del
and p.P620fsX621) also reported an expanded hypertrophic zone
exhibiting clear signs of increased ER stress [11,13]. Not only do
cells in the expanded hypertrophic zone of all of these MCDS
mouse lines exhibit an UPR but gene expression patterns are
disrupted in a similar fashion including fluctuations in steady-state
mRNA levels for collagens X and II and osteopontin (Figure 4 and
[11,13]). It has been suggested that the disruption in gene
expression patterns seen in the MCDS growth plate represents a
reprogramming of hypertrophic chondrocyte differentiation where
the chondrocyte adopts a pre-hypertrophic phenotype in order to
decrease the expression of the mutant gene and thus reduce the
level of ER stress whilst also slowing endochondral bone growth
rates [11].
The expression of VEGF by hypertrophic chondrocytes is
known to be a key factor for controlling the rate of vascular
invasion of the growth plate and a suppression of VEGF signalling
causes an expanded hypertrophic zone [6,25]. We therefore
hypothesised that if VEGF expression was affected as part of the
generalised disruption to terminal hypertrophic chondrocyte
differentiation described above and previously [11,13], the
resulting reduced rate of vascular invasion and accompanying
osteoclast erosion of the mineralised growth plate [33] would
account for the expansion of the hypertrophic zone. VEGF
expression was reduced in the m/m compared to wt/wt
hypertrophic zone resulting in a significant reduction in the
recruitment of osteoclasts to the vascular invasion front (Figure 6).
The hypertrophic zone of the m/m mouse therefore expands due
to the imbalance between the rate that cells proliferate, which is
unaffected by genotype (see BrdU labelling, Figure 3C), and the
VEGF-mediated rate at which the hypertrophic zone is degraded
by osteoclasts at the vascular invasion front.
It has been generally accepted that diseases caused by mutations
in genes encoding ECM proteins mainly result from either a
matrix that is deficient in the protein (eg haploinsufficiency) or a
defective ECM due to the presence of the secreted mutant
product. The MCDS phenotype in the Col10a1 mutant mouse is
not due to a deficiency of wildtype collagen X within the ECM
Figure 8. Western blot analysis of ColXTg
cog mouse growth
plate extracts. The panels represent two independent analyses of
growth plate extracts from wildtype (+/+), hemizygous (+/c) and mice
homozygous (c/c) for ColXTg
cog transgene. For each analysis, growth
plates from the ribs of two 21 day old mice were pooled and extracted
in sample buffer as described in the methods. Twenty micrograms of
each extract was resolved on SDS-PAGE gels under reducing conditions,
and western blotted for BiP and ATF6. Coomassie blue stained gels are
protein loading controls. For the ATF6 blot, the cleaved form (50 kDa
indicated by arrow) was readily detected in +/c and c/c mouse extracts
whereas the full-length ATF6 (90 kDa) was not detected in any samples.
A non-specific band at about 70 kDa (arrow head) was apparent.
doi:10.1371/journal.pgen.1000691.g008
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cogmousephenotype.(A)Characterisation ofthetibialhypertrophiczoneexpansioninnewborn, 3week
and 6 week old mice: (i) H & E staining at the different time points (vertical red brackets indicates the extent of the hypertrophic zone, horizontal white
scale bar=100 mm); (ii) Measurement of hypertrophic zone widths in the different genotypes (mean6SEM (n), *p,0.05 for c/c vs +/+,* * p ,0.001 for
pooled c/c and +/c vs +/+. (B) Collagen X immunohistochemistry in new born and 3 week old mice (vertical red brackets indicates the extent of the
hypertrophic zone, horizontal white scale bar=100 mm). (C) TRAP staining for osteoclasts at the vascular invasion front (vif - arrow heads,
hz=hypertrophiczone):(i)Verticalarrowsindicatepositivelystainedcells(red/browncolour);(ii)Histogramdepictingnumberofpositivecellsper1 mm
of vascular invasion front. *p,0.05, **p,0.01 (n=3 for each genotype). (D) X-ray images of 6 week old mice, scale bar=1 cm. (E) Femoral length
measurements (mean6SEM (n): *p,0.05 vs c/c; **p,0.01 vs +/+;
{p,0.05 vs pooled c/+ and c/c).
doi:10.1371/journal.pgen.1000691.g009
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the protein do not exhibit the characteristic expanded hypertro-
phic zone accompanied by reduced bone growth [13,34,35].
Other explanations, apart from ER stress, for how mutant collagen
X could be causing MCDS include the possibility that collagen X
interacts in the ER with another secreted component(s), the
absence of which causes the phenotype. The intracellular retention
of the mutant collagen X would lead to the retention of this second
component in a similar fashion to that proposed for the role of
mutant COMP in the pathogenesis of pseudoachondroplasia [8].
Mutations in this second locus might also be expected to cause an
MCDS-like phenotype and such a second locus has been proposed
(see [4]). Alternatively, the limited secretion of mutant collagen X
(Figure 4A; m/m mouse) may create a defective extracellular
environment that contributes to the phenotype.
It has been appreciated for some time that increased ER stress
and the resulting UPR can play an important role in diseases
involving tissues dedicated to the synthesis of extracellular proteins
such as the pancreas or liver [e.g. 36–38]. Only recently, however,
has evidence for the potential contribution of ER stress to disease
pathogenesis across a range of connective tissue diseases begun to
be appreciated. Several studies on mouse models of ECM diseases
caused by mutations in secreted ECM proteins such as aggrecan
[11], collagen I [16], collagen II [11], collagen IV [12], collagen X
[11,13], COMP [14], matrilin 3 [15] and mucin [17] have
reported increased levels of ER stress and speculated upon the
possible role played by ER stress in the respective disease
mechanisms. In order to directly test the putative role of elevated
ER stress and the UPR in the disease mechanism of the mutant
collagen X mouse line described above, we generated a transgenic
mouse in which an UPR was specifically targeted to hypertrophic
chondrocytes. The Tg
cog protein used to induce the UPR had
previously been shown to trigger a similar ER stress response to
that described for collagen X mutations (Figure 5 and [10,11]),
and is efficiently retained intracellularly not only in thyrocytes but
also when expressed in heterologous cell lines [26,27].
Expression of the Tg
cog protein in hypertrophic chondrocytes
induced an UPR very similar to that provoked by the mutant
collagen X (cf Figure 5 and Figure 8). It is noteworthy that
expression of Tg
cog did not cause any generalised secretion defect
since the wildtype collagen X synthesised in the same cells appeared
to be secreted normally with no evidence of intracellular retention
(Figure 9B). Nevertheless, the Tg
cog -expressing mouse exhibited an
expanded growth plate hypertrophic zone with decreased numbers
of osteoclasts at the vascular invasion front and decreased rates of
bone growth (Figure 9), a phenotype reminiscent of the mutant
collagen X mouse (Figure 2 and Figure 3). In addition, Tg
cog caused
changes in the expression patterns of other genes in the
hypertrophic zone similar to those produced by MCDS-causing
mutant forms of collagen X reported here and elsewhere (Figure 10
and[11,13]).Thesedata fromthe ColXTg
cogmousedemonstrate that
the predominant pathological features of MCDS can be phenocop-
ied by simply elevating ER stress and provoking an UPR in
hypertrophic chondrocytes. We therefore conclude that potential
extracellular consequences of the secretion of mutant collagen X do
not appear to play a major role in the pathogenic mechanism.
Furthermore, since the wildtype collagen X synthesised by the
ColXTg
cog mouse was not retained but secreted normally (Figure 9B),
the defective secretion of a putative binding partner for collagen X
seems unlikely as a potential pathogenic factor. The phenotype of
the ColXTg
cog mouse demonstrates mechanistically the central role
played by ER stress in the MCDS disease process.
How might the UPR be inducing the disruption in hypertrophic
chondrocyte differentiation resulting in the MCDS phenotype? In
Figure 10. In situ hybridisation comparing the ColXTg
cog and MCDS phenotype. Tibial growth plates from 3 week old mice homozygous for
either the ColXTg
cog or Col10a1 p.Asn617Lys mutations were analysed for the expression of mRNAs encoding thyroglobulin, collagen X, BiP, collagen
II, and osteopontin as indicated. The vertical red bars delineate the hypertrophic zones.
doi:10.1371/journal.pgen.1000691.g010
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cog mouse lines,
hypertrophic differentiation appeared to start normally with the
up-regulation of collagen X expression (Figure 4B and Figure 10).
However, in these mouse lines, the expression of the collagen X
gene equates to the induction of increased ER stress and an UPR
due to the synthesis of a mutant protein (collagen X and Tg
cog in
the respective mouse models). Expression of either of the mutant
proteins correlated directly with the induction of mRNA for BiP
(Figure 10) which is indicative of an UPR. Subsequently, the levels
of mRNAs encoding the mutant proteins decreased dramatically
(Figure 10) and this is presumably accompanied by a decreased
rate of synthesis of the ER stress-inducing protein. The closely
related reduction in BiP mRNA suggests that at this point,
hypertrophic chondrocytes had established an UPR which was
effectively dealing with the accumulated unfolded protein thus
restoring homeostasis to the ER. Supporting this contention is the
observation that a reduction in the intracellular accumulation of
mutant collagen X and its delayed secretion (Figure 4A inset)
appeared to correlate with the generalised down-regulation of BiP
mRNA (Figure 4B). One possible explanation for how an UPR
could cause a reduction in steady state levels of mRNA for
particular genes may reside in the accompanying attenuation of
general protein synthesis due to eIF2a phosphorylation [19–22]
which could impact upon steady state levels of transcription factors
driving the chondrocyte differentiation process. Decreases in these
transcription factors would result in transcriptional attenuation for
dependant genes. Such an explanation would account for why the
wildtype collagen X gene expressed in the ColXTg
cog mouse was
down-regulated in a similar fashion to the Tg
cog transgene
(Figure 10) and demonstrates that the effects of an UPR on
transcription are generic and not in some way targeted at loci
producing the mutant transcripts. The loss of these transcription
factors would also explain the failure to induce significant
expression of VEGF which, as discussed above, results in the
expanded hypertrophic zone. Alternatively, the rapid degradation
of a subset of ER-localised mRNAs catalysed by IRE1 in response
to increased ER stress has been reported [39] and a similar
phenomenon may be occurring in hypertrophic chondrocytes.
The relationship between UPR and transcription is complex [40]
and future work will address this relationship in these mouse lines.
Once the initial ER stress induced by the expression of mutant
collagen X or the Tg
cog transgene has been dealt with, the
chondrocytes appear to revert to a prehypertrophic phenotype
characterised by the re-expression of collagen II (Figure 10),
PTHrP receptor and Indian hedgehog ([11,13] and data not
shown) prior to re-initiating terminal differentiation including
collagen X expression. This re-engaging of the differentiation
process is not synchronised in the lower half of the expanded
hypertrophic zones and gives rise to the characteristic ‘speckled’
pattern of gene expression seen. Completion of the terminal
differentiation step, hypertrophy, is achieved in a highly
synchronised fashion in the normal growth plate as evidenced by
the expression of markers such as osteopontin by a one or two cell
deep layer adjacent to the vascular invasion front (wildtype,
Figure 10). However, individual cells scattered throughout the
lower half of the expanded hypertrophic zones express osteopontin
in a non-coordinated fashion (Figure 10 and [11,13]). The
disruption and delay in the terminal differentiation of hypertrophic
chondrocytes including the reduced VEGF signalling (Figure 6
and Figure 10) caused by the UPR results finally in reduced rates
of bone growth. It is noteworthy that for mice heterozygote for the
collagen X mutation and mice hemi- or homozygous for the
ColXTg
cog allele, reduced rates of bone growth could only be
detected in juvenile, rapidly growing animals (Table 1 and Figure 9
respectively). In all these genotypes, the bone lengths achieved by
10 weeks of age were not significantly different from wildtype
controls meaning that the decreased rates of bone growth
exhibited in juvenile mice were compensated for as bone growth
rates decreased into adulthood (Table 1). In the case of the
ColXTg
cog mouse line, it is possible that the regression of the
pathology is in part due to transgene silencing in maturing animals
as reported for the Col10al.13 del mouse [11]. However, Tg
cog and
elevated BiP expression were still detectable in animals at 6 weeks
of age (data not shown). In addition, the promoter used in the
current study to drive Tg
cog expression was significantly longer
than that used in the previous study [11] and contained all the
sequences necessary to direct bona fide collagen X expression [41].
The regression of pathology in the wt/m Col10a1 mutant mouse is
unlikely to be due to gene silencing since in this line, expression
was driven by the endogenous collagen X promoter. It seems more
likely that, as discussed below, regression of pathology is related to
reduced levels of ER stress being experienced in the growth plate
as the rates of growth decrease into adulthood. In humans it has
also been reported that some of the milder skeletal changes
associated with MCDS appear to regress with age [42].
These observations raise several important points and questions.
Firstly, how does disease severity relate to the level of ER stress
experienced? Several different factors may influence the level of
ER stress experienced by a cell. Previous studies have clearly
demonstrated a gene dosage effect relating the level of mutant
collagen X expression, and therefore the level of ER stress
experienced, to the disease severity [11,13]. Likewise, in this study,
wt/m and +/c mice had significantly milder phenotypes than their
homozygote counterparts. Natural, growth-related alterations in
the level of gene expression may account in part for the transient
expansion of the hypertrophic zone apparent in growth plates of
wt/m and +/c animals at 3 weeks of age as peak growth rates are
achieved (Figure 3 and Figure 9). In addition, the milder
phenotype of mice homozygous for the Tg
cog allele which exhibit
no permanent dwarfing in comparison with the mutant Col10a1
allele may relate to the fact that the former transgene is expressed
at only around one third the level of the latter. It is also possible
that different mixed genetic backgrounds account for some of the
variations in phenotype noted between lines such as the earlier
onset of hypertrophic expansion apparent in the +/c mice at birth.
Other factors that will influence the level of ER stress experienced
by a cell include: the nature of the mutation which may interfere
with protein folding in different ways producing misfolded proteins
that are more or less easily dealt with by the cell; and the
behaviour of the misfolded protein is also critical since, as recently
demonstrated for mutant forms of type I collagen, aggregates in
the ER trigger autophagy whereas non-aggregated forms are
subject to ER associated degradation [43]. In this manner,
different mutations in the same protein may produce different
levels of ER stress and therefore account, at least in part, for the
spectrum of clinical phenotype seen in MCDS [4].
Secondly, the transient nature of the phenotype in our
heterozygote mouse lines coupled to the fact that some of the
skeletal pathology associated with MCDS in humans appears to
regress with age raises the possibility that relatively modest
decreases in the level of ER stress may produce significant
improvements in clinical severity. Methods of reducing ER stress
using chemical chaperones [44] or drugs designed to reduce ER
stress by targeting pathways that control the stress response itself or
mechanisms of degradation for misfolded proteins [45] are being
developed and these represent possible novel therapeutic oppor-
tunities for treating MCDS. Finally, the fact that increased ER
stress and the resulting UPR is of pathogenic significance in
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contention that such stress may play a significant role in the
pathogenesis of many of the connective tissue diseases that are
caused by mutations in ECM or related genes [11–18].
Materials and Methods
Generation of mutant mice
Col10a1 p.Asn617Lys mouse line: Gene targeting was per-
formed as described [46]. Briefly, an SV129 DNA library (RPCI)
was screened and the PAC clone number 628-I3 identified as
encoding the Col10a1 gene. The BglII-BamHI 470 bp fragment of
DNA flanking the Asn617 position (nucleotide 1849–1851 of the
cDNA sequence from the ATG start codon) was amplified using
primers: Forward: CAA GAT CTG GTA TCT TTA CCT GTA
AGA TCC and Reverse: GAG GAT CCT CAC ATA CCC ACT
GTT ACT G, and subcloned into pGEM-Teasy as per
manufacturers instructions. The single base pair change required
to produce the p.Asn617Lys mutation (C1851A) was introduced
using the QuikChange XL site directed mutagenesis kit (Strata-
gene) with the following primers (mutated base underlined): F:
CGT TTG GGT AGG CCT GTA TAA GAA AGG CAC GCC
TAC GAT GTA CAC and R: GTG TAC ATC GTA GGC GTG
CCT TTC TTA TAC AGG CCT ACC CAA ACG. The
presence of the mutation was confirmed by direct sequencing. The
59 6194 bp BglII fragment was ligated upstream of the mutated
fragment and the 2045 bp BamHI/EcoR1 fragment encoding
downstream sequence was inserted 39 to it (see Figure 1A). A LoxP-
flanked Neo TK selection cassette was ligated into the unique Sgf1
site located approximately 200 bp 39 to the stop codon. The
construct was then linearised by digestion with NotI, electropo-
rated into mouse R1 (SV129) ES cells and 360 G418 resistant
clones were picked and frozen down as described [46].
Homologously recombined clones were screened for by EcoRV
digestion and Southern blot analysis with the external probe
indicated (Figure 1A and 1B). Homologously recombined clones
were subsequently transiently transfected with the Cre recombinase
gene and selected with FIAU to remove the floxed Neo TK
selection cassette as described [15]. Correctly targeted clones were
used to generate germline chimeras [46]. Mice carrying the
Col10a1 mutation (which was confirmed by direct sequencing,
Figure 1D) were maintained on an SV129/C57Bl6 mixed
background. Genotyping was performed using primers (F: GAT
TTA TGG TGA GTT AGA GTC and R: GTG AGC ACT TCC
TGT CAA GC) flanking the LoxP site (Figure 1A and 1C).
ColXTg
cog mice: pBS was digested with KpnI and SacI to remove
the multiple cloning site which was replaced with a double
stranded oligo encoding the following sites: SgfI, XhoI, PmeI,
NotI, SgfI. An 8276 bp XhoI fragment from PAC 628-I3
equivalent to base pairs 26809230 to 26817511 of mus musculus
chromosome 10 genomic contig NT_039492, and including exons
1 and 2 and the 59 portion of exon 3 was isolated. This region
encompasses sequence 4.6 kb upstream of the start site and
includes all the putative cis acting promoter and enhancer
elements reported to drive specific hypertrophic chondrocyte
expression [41]. The collagen X translation start site and two
subsequent ATG’s were removed by overlapping PCR. The
8.5 kb cDNA encoding the cog mutant form of thyroglobulin,
including the start codon and polyA signal was subcloned in 2
stages. Firstly the 59 8 kb Pme1-Not fragment was subcloned
followed by the 400 bp 39 Not1 fragment containing the polyA
addition signal. The construct was verified by sequencing across
ligation boundaries, removed from the vector by digestion with
SgfI, and the purified DNA used for pronuclear injection into
donor blastocysts which were implanted into pseudopregnant
foster mothers. Offspring were assessed for the presence of the
transgene by PCR between the collagen X promoter and the
Tg
cog, as indicated (Figure 7A), with the following primers: ColX-
GenF: GGA CTG TTG TGT GAG TGG and Tg
cog-GenR:
TTC CAT CTT CAG AGC ACT GG. Hemizygous (+/c) and
homozygous (c/c) genotypes were determined by quantitating the
relative levels of the transgene using the primers described above
in real-time PCR (see below) on genomic DNA.
Real-time PCR
Expression levels of Tg
cog mRNA in transgenic mice were
assessed as follows: New born rib growth plates were placed in
RNAlater (Sigma), homogenised, put through a QIAshredder
(Qiagen), and RNA extracted using the Qiagen RNAeasy kit
(Qiagen). The RNA was DNaseI (Ambion Inc.) treated and
Superscript III reverse transcriptase with random hexamers
(Invitrogen Ltd.) was used to generate cDNA. Real-time analysis
of the relative expression of Tg
cog to that of collagen X was
performed using the following intra-exon primer pairs: Tg-RT-F:
AGG CAT GTG CAG TGT GAT GG and Tg-RT-R: GGT
ACT GTG CTA GCA CTG G, and ColX-RT-F: CTT CCT
GTC AAG CTC ATC C and ColX-RT-R: TAG GAT TGC
TGA GTG CTC C. Wildtype genomic DNA was used as one
control together with a no-template control to check for
contamination. All reactions were performed in duplicate using
SYBR Green Kit on an ABIPrism 7000 sequence detector system
(Applied Biosystems Ltd).
Skeletal analyses
Skeletal preparations of newborn mice were prepared as
described [47]. X-rays of mice were produced using a Flaxitron
X ray specimen radiography system (Flaxitron) and X-ray film
(Kodak). Bone length measurements were taken from radiographic
images. All the measurements were analysed by ANOVA for
statistical significance.
Histology and immunohistochemistry
Bone samples were fixed overnight in either 95% ethanol/5%
acetic acid or in ice-cold 4% PFA. They were then decalcified in
0.25 M EDTA, embedded in paraffin wax and sectioned sagittally
and mounted on positively charged glass slides. For haemotoxylin
and eosin (H & E) staining, the slides were dewaxed in xylene,
rehydrated and H and E stained using a ThermoShandon Ltd
automated stainer, dehydrated in an ethanol gradient, cleared in
xylene and mounted using a xylene-based mounting solution.
Hypertrophic zone width measurements were taken in the
central part of the image. The start of the zone was defined as the
point at which the disc shape cells of the proliferative zone started
to round up and become larger, and the end of the zone taken as
the vascular invasion front. Measurements were performed using
the Photoshop Ruler Tool on images of known magnification. For
each animal, three separate sections spaced at least 75 mm apart
were averaged.
Immunohistochemistry against collagen X was carried out on
ethanol/acetic acid-fixed samples. A rabbit polyclonal antibody to
recombinant mouse collagen X NC1 domain was produced
(Eurogentec). Briefly, a Antibodies to BrdU, and the myc epitope
(Roche -) were used on PFA fixed tissue as described [48]. BrdU
labelling was carried on 3 week old mice which were injected
intraperitoneally with 100 mg BrdU (Sigma) per kg body weight,
and sacrificed 2 hours later. Tibias were fixed in ice-cold 4% PFA,
demineralised in 4% PFA containing 0.25 M EDTA and
sectioned as described above. Antigen unmasking was performed
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The number of BrdU-labelled cells was expressed as a proportion
of the total population of cells in the proliferative zone which was
defined as the region of the growth plate in which chondrocytes
are disc shaped and form columns. Images were prepared using a
Carl Zeiss Axiocam Colour CCD camera with associated
Axiovision software and processed using Adobe Photoshop.
In situ analysis
In situ hybridisation using
35S-labelled RNA probes was carried
out as described [49]. DIG labelled colourimetric in situ was
performed as described [50]. Tibias from 3 week old animals were
fixed in ice-cold 4% PFA, demineralised in 4% PFA containing
0.25 M EDTA and sectioned as described above. The collagen II
probe was a 600 bp insert encoding 39 UTR from I.M.A.G.E
cloneID 735113; the collagen X probe was a 900 bp fragment the
39 end of the coding sequence; the osteopontin probe was the 1 kb
fragment from I.M.A.G.E cloneID 1481264; and the BiP probe
was a 350 bp fragment from I.M.A.G.E cloneID 6334883. The
VEGF probe was as described [51]; the thyroglobulin probe was a
700 bp cDNA fragment amplified using primers F: TTG TAG
ATC CAT CCA TCA AGC and R: GTG ACT ACG ATG AAG
TTG C. cDNA probes were cloned into pT7T3, linearised and
transcribed using the appropriate restriction enzyme and RNA
polymerase respectively.
Western blotting
Rib growth plate tissue was dissected from 3 week old animals,
homogenised and boiled in SDS loading buffer containing DTT
and centrifuged before loading (20 mg protein per sample) on
SDS–PAGE gels. The protein concentration of extracts was
assayed using the Pierce bicinchoninic acid (BCA) protein assay kit
with a bovine serum albumin standard curve. The gel was
electroblotted onto a nitrocellulose membrane, which was blocked
overnight with 2% skimmed milk powder in PBS-T. Primary
antibodies (Grp78/BiP - Santa Cruz (sc-1051) and ATF6 -
Imgenex (IMG-273)) were diluted 1:500 in the blocking solution
and the appropriate secondary antibody (goat anti-rabbit (1:1000)
or goat anti-mouse (1:10 000) - ThermoFisher Scientific Ltd) was
diluted in PBS-T. An ECL detection kit (Perkin-Elmer Inc.) was
used to develop the blots according to manufacturer’s protocol.
Tartrate-resistant Acid Phosphatase (TRAP) staining
Osteoclasts at the vascular invasion front were stained using the
Acid Phosphatase kit from Sigma. The protocol was performed as
per the manufacturer’s instructions, on PFA fixed sections. For
each genotype, 3 animals were assessed and for each animal, three
separate sections spaced at least 50 mm apart were analysed.
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